Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC9107855/ Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection - PMC While there is absolutely no evidence to ensure recovered patients are either likely or unlikely to get reinfected. But studies in non-human primates indicate... primary immune responsesars cov 2 https://www.wikidata.org/wiki/Q36269111 The rate of division of antibody-forming cells during the early primary immune response - Wikidata